FMP
Leap Therapeutics, Inc.
LPTX
NASDAQ
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
0.4 USD
0.0068 (1.7%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Douglas E. Onsi J.D.
sector
Healthcare
industry
Biotechnology
website
https://www.leaptx.comexchange
NASDAQ
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in ...
CIK
0001509745
ISIN
US52187K2006
CUSIP
52187K101
Address
47 Thorndike Street
Phone
617 714 0360
Country
US
Employee
52
IPO Date
Jan 25, 2017
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
LPTX Financial Summary
CIK
0001509745
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
52187K101
ISIN
US52187K2006
Country
US
Price
0.4
Beta
0.21
Volume Avg.
2.51M
Market Cap
16.5M
Shares
-
52-Week
0.222-4.79
DCF
1.25
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.22
P/B
-
Website
https://www.leaptx.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest LPTX News
It looks like there's no news available.
